Clinical trial

NAFLD Among Patients With Type 2 Diabetes and CKD

NCT03826381

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2019-05-06

PhaseN/A

Study timeline

Study start (actual)2019-05-06Date precision: day

Registry last updated2021-09-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Alcoholic Fatty Liver Diseaseunresolved

Chronic Kidney Diseasesunresolved

Type2 Diabetesunresolved

Interventions

Magnetic resonance (MR) spectroscopy of the liverDIAGNOSTIC_TEST

FibroscanDIAGNOSTIC_TEST

Continuous glucose monitoring (CGM) for four days.DEVICE

Dual Energy X-ray Absorptiometry (DEXA) scanRADIATION

Blood samplesBIOLOGICAL

Clinical and demographic dataOTHER

Sponsors & collaborators

Copenhagen University Hospital, Rigshospitaletlead sponsor

Mapped research locations

CopenhagenDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03826381 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.